Cargando…
Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients
BACKGROUND: Guidelines advise the use of antibacterials (ABs) in the management of COPD exacerbations. COPD patients often have multiple comorbidities, such as diabetes mellitus and cardiac diseases, leading to polypharmacy. Consequently, drug–drug interactions (DDIs) may frequently occur, and may c...
Autores principales: | Wang, Yuanyuan, Bahar, Muh Akbar, Jansen, Anouk M E, Kocks, Janwillem W H, Alffenaar, Jan-Willem C, Hak, Eelko, Wilffert, Bob, Borgsteede, Sander D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814093/ https://www.ncbi.nlm.nih.gov/pubmed/31127283 http://dx.doi.org/10.1093/jac/dkz221 |
Ejemplares similares
-
The impact of CYP2D6 mediated drug–drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine
por: Bahar, Muh. Akbar, et al.
Publicado: (2018) -
Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020) -
Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study
por: Wang, Yuanyuan, et al.
Publicado: (2020) -
Discontinuation and dose adjustment of metoprolol after metoprolol‐paroxetine/fluoxetine co‐prescription in Dutch elderly
por: Bahar, Muh. Akbar, et al.
Publicado: (2018) -
Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)